在胃食道病变中,瘤进展的预测因素是不确定的,因为缺血症
Valentina Angerilli1, Francesca Galuppini1, Stefano Brignola2
1Department of Medicine (DIMED), Surgical Pathology and Cytopathology Unit, University of Padua, Padua, Italy.
Histopathology
|March 26, 2025
概括
在无限期性发育不良 (IND) 病变中,瘤进展的风险与超增殖性肠道代谢 (HIM) 有关. 定期对巴雷特食道进行内镜,用于胃IND (G-IND) 进行IND (BE-IND) 和OLGA分期,以改善风险分层.
科学领域:
- 胃肠病学 胃肠病学
- 病理学 病理学 病理学
- 在瘤学瘤学.
背景情况:
- 在预测瘤进展方面,巴雷特食道与无限期形 (BE-IND) 和胃无限期形 (G-IND) 诊断存在挑战.
- 对于这些上部胃肠道疾病进展的预后因素的了解有限.
研究的目的:
- 确定预测BE-IND和G-IND患者瘤进展的组织学和临床病理学因素.
- 改善被诊断为无限期发育不良症的患者的风险分层和管理策略.
主要方法:
- 一项回顾性研究包括了经确认的BE-IND和G-IND患者,而没有先前的发育不良或癌症.
- 采用多变量考克斯回归分析来确定进展的风险因素,并根据人口统计和组织学特征进行调整.
- 计算了进展率,并分析了特定的因素,如高增殖性肠道转化症 (HIM) 类型,间隔内镜和胃炎评估 (OLGA) 的操作链接分期.
主要成果:
- 仅在无限期内观察到新发性进展,用于超增殖性肠子代谢 (HIM) 类型的发育不良.
- 在BE-IND中,每100人/年增长率为4.4,在G-IND中,每100人/年增长率为1.6.
- 对于G-IND,OLGA阶段III-IV是进展的显著预测因素 (HR=47.82,P<0.001). 缺少间隔内镜显著增加了BE-IND风险 (HR=13.45,P=0.032).
结论:
- 不确定的发育障碍 (IND) 是一个困难的诊断,与瘤风险增加有关,特别是在BE-IND.
- 超增殖性肠道代谢 (HIM) 类型是IND病变中瘤进展的主要驱动因素.
- 定期间隔内镜用于BE-IND和G-IND的OLGA分期对于有效的风险分层和患者管理至关重要.
相关概念视频
Barrett Esophagus-I: Introduction
49
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
49
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Barrett Esophagus-II: Clinical Manifestations and Management
90
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
90
Esophageal Strictures-I: Introduction
44
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
44
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
72
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
72


